September 2020—GenMark Diagnostics announced that its ePlex Respiratory Pathogen 2 Panel is available for U.S. commercial distribution and clinical use.
The ePlex RP2 Panel is a rapid-result multiplex panel test that can identify 21 pathogens, including SARS-CoV-2, influenza, adenovirus, rhinovirus, and respiratory syncytial virus, in less than two hours. The panel is designed for use with GenMark’s ePlex system.
Pages: 1 2